Darunavir (TMC114) approved by the FDA.
D000818:Animals; D000069454:Darunavir; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004353:Drug Evaluation, Preclinical; D024882:Drug Resistance, Viral; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D000069454:Darunavir